SOFOSLED® is a treatment for patients with chronic hepatitis C virus genotypes 1,3,4,5 and 6.
This medicine is interferon-free, it can be taken with or without ribavirin.
| DCI | SOFOSBUVIR / LÉDIAPASVIR |
|---|---|
| Dosage | 400/90 mg |
| Trade name | SOFOSLED® |
| Name of the originator | HARVONI |
| Presentation | 28 tablets |
| Specialty | Hépatologie-AAD |
